InvestorsHub Logo
Followers 38
Posts 2912
Boards Moderated 0
Alias Born 06/05/2012

Re: Lemoncat post# 323761

Tuesday, 09/15/2020 11:35:52 PM

Tuesday, September 15, 2020 11:35:52 PM

Post# of 403022
And you are WRONG yet again. You can set up ”efficacy” as a strawman all you want but that changes nothing. I value both safety and efficacy because it takes both. I say that Brilacidin is more “advanced” because it is. The most “advanced” drug will be the first to market and THAT is why Brilacidin is more “advanced” than Ab8. The most time consuming steps any drug must go through involve human trials. Ab8 has to go through Phase 1 safety trial(s) before it can begin to think about Phase 2 human trials. And since none of the articles I’ve seen on Ab8 even talk about human trials, I think it fair to assume that they are nowhere near ready to start them. Brilacidin’s Phase 2 for Covid will be completed before Ab8 even begins a Phase 1. Meanwhile, Brilacidin is preparing to engage with the FDA even as we speak to start a Phase 2 human trial for Covid. Please read the statement at the bottom of my post.

Lemoncat said,

You value safety over efficacy. That's fine. I don't. Apparently neither does the market.

You can argue the point all you want. I say Ab8 is more advanced than Brilacidin when it comes to efficacy.


"It is difficult to get a man to understand something, when his salary depends upon his not understanding it."

Upton Sinclair

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News